“…Presently, the most effective treatment for schizophrenia involves the use of antipsychotic medications (Rittmannsberger, Pachinger, Keppelmuller, & Wancata, 2004). However, growing concerns over rapidly rising expenditures for these drugs have made benefit versus price a critical issue (Fichtner, Hanrahan, & Luchins, 1998;Gardner et al, 2003;Gibson, Dalmer, Jackson, Wilder, & Ramsey, 2004;Hogan, 1999). Faced with skyrocketing Medicaid expenditures, many states are adopting restrictive prescribing policies (e.g., mandatory generic requirements, prior authorization, medication algorithms, drug formulary restrictions, and preferred drug lists) to contain these costs (Awad & Voruganti, 2004;Becker & Lemrow, 2004;Boyd, 2003;Geddes, Freemantle, Harrison, & Bebbington, 2000).…”